Showing results (1-10 of 208) with videos related to
Sort By:
Pageof 21
Seminars in Dialysis|January 13, 2016
Update on the End-Stage Renal Disease Quality Incentive ProgramRimda Wanchoo, Azzour D Hazzan, Steven FishbaneKidney International|January 10, 2014
Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancerAzzour D Hazzan, Hitesh H Shah, Susana Hong, et al.Seminars in Nephrology|May 29, 2016
Ferric Pyrophosphate Citrate: A Novel Iron Replacement Agent in Patients Undergoing HemodialysisHitesh H Shah, Azzour D Hazzan, Steven FishbaneCurrent Opinion in Nephrology and Hypertension|June 8, 2015
Novel iron-based phosphate binders in patients with chronic kidney diseaseHitesh H Shah, Azzour D Hazzan, Steven FishbaneClinical Kidney Journal|February 26, 2015
Challenges and opportunities in late-stage chronic kidney diseaseSteven Fishbane, Azzour D Hazzan, Candice Halinski, et al.Advances in Chronic Kidney Disease|June 22, 2016
Epidemiology and Challenges to the Management of Advanced CKDAzzour D Hazzan, Candice Halinski, Sofia Agoritsas, et al.Clinical Journal of the American Society of Nephrology : CJASN|March 31, 2016
Bone Parameters and Risk of Hip and Femur Fractures in Patients on HemodialysisSteven Fishbane, Azzour D Hazzan, Kenar D Jhaveri, et al.Kidney International Reports|January 11, 2018
Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative ReviewKenar D Jhaveri, Rimda Wanchoo, Vipulbhai Sakhiya, et al.BMC Nephrology|June 23, 2018
Practice patterns in transitioning patients from chronic kidney disease to dialysis: a survey of United States nephrologistsMary C Mallappallil, Steven Fishbane, Rimda Wanchoo, et al.Clinical Kidney Journal|August 9, 2018
Medication discrepancies in late-stage chronic kidney diseaseJamil Ibrahim, Azzour D Hazzan, Anna T Mathew, et al.Pageof 21